Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension

被引:118
|
作者
Cerasola, G
Cottone, S
Mule, G
Nardi, E
Mangano, MT
Andronico, G
Contorno, A
LiVecchi, M
Galione, P
Renda, F
Piazza, G
Volpe, V
Lisi, A
Ferrara, L
Panepinto, N
Riccobene, R
机构
[1] UNIV PALERMO,CHAIR INTERNAL MED,PALERMO,ITALY
[2] UNIV PALERMO,DIV CLIN PATHOPHYSIOL & HYPERTENS,PALERMO,ITALY
关键词
microalbuminuria; left ventricular hypertrophy; hypertensive nephropathy; hypertensive retinopathy; target organ damage;
D O I
10.1097/00004872-199607000-00016
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To evaluate the prevalence of microalbuminuria (albumin excretion rate, AER) in a wide hypertensive population, and to evaluate any relationship with cardiovascular damage and renal dysfunction. Design A transversal study. Subjects and methods In 383 hospitalized Caucasian essential hypertensives (198 men, 185 women) of mean age 44 +/- 0.5 years and mean clinic blood pressure 170.3 +/- 0.95/103.4 +/- 0.47 mmHg, metabolic parameters, serum creatinine level (C-S), creatinine clearance rate (C-CR), 24 AER and plasma renin activity (PRA) were measured. Furthermore, each patient underwent 24 h ambulatory blood pressure monitoring (ABPM) and echocardiography to measure left ventricular mass, which was indexed both by body surface area to obtain left ventricular mass index (LVMI) and by height to obtain the left ventricular mass indexed for height (LVMH). By Doppler echocardiography, the diastolic compliance by early:late peak filling velocity ratio was analysed. The fundus oculi was also observed. Three subsets of hypertensives were obtained by dividing the 383 essential hypertensives on the basis of their AER: less than or equal to 11 (group A), 11 less than or equal to 20 (group B) and > 20 mu g/min (group C). Main outcome measures Microalbuminuria, creatinine clearance, PRA, ABPM, LVMI, LVMH, early:late peak filling velocity ratio, hypertensive retinopathy. Results Among the 383 essential hypertensives, AER was <11 mu g/min in 55% of the patients (group A), 18% had AER in the range 11-20 mu g/min (group B) and 27% had AER >20 mu g/min (group C). In the entire essential hypertensive population the prevalence of left ventricular hypertrophy was 44.39% and hypertensive retinopathy was observed in 54.83%. Moreover, AER significantly correlated with clinic systolic blood pressure (SEP) and diastolic blood pressure (DBP), with 24 SBP and DBP and with 24 h daytime and night-time mean blood pressure (MBP). AER was correlated also with LVMH and creatinine clearance. The analysis of the three subsets revealed no differences in age, body mass index, serum creatinine level and PRA. Group C in comparison with group A showed higher values of clinic SEP, 24 h SBP, DBP and MBP, and of daytime and nighttime MBP. Furthermore, in group C, LVMI and LVMH were significantly greater than in group A, with a prevalence of left ventricular hypertrophy of 55% in the former group. Group C showed a prevalence of hypertensive retinopathy of 69% whereas in group A the prevalence was 48%. In group C, AER was significantly correlated with serum creatinine level. Conclusion The transversal phase of our research, performed in a homogeneous population of Caucasian essential hypertensives with no metabolic disturbances, confirms the relationship between blood pressure pattern and early glomerular changes in essential hypertensives without overt proteinuria. Furthermore, these results emphasize the role of microalbuminuria as a marker of early cardiac, renal and retinal structural and functional changes in essential hypertension. The longitudinal study, which is in progress, will confirm the prognostic value of microalbuminuria in essential hypertension.
引用
收藏
页码:915 / 920
页数:6
相关论文
共 50 条
  • [41] MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION
    LJUNGMAN, S
    AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (12) : 956 - 960
  • [42] Development of microalbuminuria in essential hypertension
    Josep Redon
    Jose M. Pascual
    Current Hypertension Reports, 2006, 8 : 171 - 177
  • [43] MICROALBUMINURIA IN ESSENTIAL-HYPERTENSION
    REDON, J
    PASCUAL, JM
    MIRALLES, A
    SANZ, C
    GUTIERREZ, M
    ROS, MJ
    BALDO, E
    MICHAVILA, J
    SANCHEZ, C
    ALEGRE, B
    MEDICINA CLINICA, 1991, 96 (14): : 525 - 529
  • [44] THE DIAGNOSIS OF ESSENTIAL-HYPERTENSION (STUDY OF RENAL BIOPSY SPECIMENS AND MICROALBUMINURIA)
    ARABIDZE, GG
    SOKOLOVA, RI
    TITOV, VN
    TARASOV, AV
    TERAPEVTICHESKII ARKHIV, 1989, 61 (09) : 8 - 12
  • [45] CALCIUM ANTAGONISM IN ESSENTIAL-HYPERTENSION - EFFECT ON RENAL HEMODYNAMICS AND MICROALBUMINURIA
    PERSSON, B
    ANDERSSON, OK
    WYSOCKI, M
    HEDNER, T
    KARLBERG, B
    JOURNAL OF INTERNAL MEDICINE, 1992, 231 (03) : 247 - 252
  • [46] Renal participation in cardiovascular risk in essential hypertension
    Ruilope, LM
    Rodicio, JL
    BLOOD PRESSURE, 2001, 10 (5-6) : 322 - 326
  • [47] Erectile dysfunction and microalbuminuria in essential hypertension: evidence for two interrelated pathologies of the vasculature
    Kakkavas, A.
    Tsioufis, C.
    Tsiachris, D.
    Dimitriadis, K.
    Thomopoulos, C.
    Tousoulis, D.
    Stefanadis, C.
    Kallikazaros, I.
    EUROPEAN HEART JOURNAL, 2007, 28 : 248 - 248
  • [48] Endothelial dysfunction and the kidney: Emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension
    Zoccali, Carmine
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04): : S61 - S63
  • [49] Renal Resistive Index and Cardiovascular and Renal Outcomes in Essential Hypertension
    Heine, Gunnar H.
    Rogacev, Kyrill S.
    Fliser, Danilo
    Krumme, Bernd
    HYPERTENSION, 2013, 61 (02) : E22 - E22
  • [50] Renal Resistive Index and Cardiovascular and Renal Outcomes in Essential Hypertension
    Doi, Yohei
    Iwashima, Yoshio
    Yoshihara, Fumiki
    Kamide, Kei
    Hayashi, Shin-ichirou
    Kubota, Yoshinori
    Nakamura, Satoko
    Horio, Takeshi
    Kawano, Yuhei
    HYPERTENSION, 2012, 60 (03) : 770 - +